Etiological spectrum of isolated ileo-cecal ulcers in patients with gastrointestinal symptoms
Background: Isolated ileo-cecal region ulcers may represent underlying Crohn’s disease, intestinal tuberculosis, bacterial infections (including typhoid), amoebiasis, eosinophilic enteritis, drug-induced sequelae, or neoplasm. Overlapping morphological and microscopic characteristics of many of these diseases make it challenging to unequivocally confirm a diagnosis.
Aims: To investigate the etiology and clinical outcomes of isolated ileo-cecal ulcers discovered during an ileocolonoscopy in patients with gastrointestinal symptoms.
Methods: Patients with isolated ileo-cecal ulcers and symptoms within the age range of 10 to 80 years were included (N = 100). Patients not giving consent (assent in case of a minor), with a prior diagnosis of tuberculosis or inflammatory bowel disease, with incomplete colonoscopy and associated colonic lesions other than ileo-cecal region were excluded from the study. Demographics, clinical information, and relevant biochemical and serological tests were recorded. During the colonoscopy, multiple biopsies were taken from the ileo-cecal ulcers for histopathological examination. Repeat ileocolonoscopy was performed as needed in consenting patients.
Results: The mean age and mean duration of symptoms were 36.0 ± 15.6 years and 18.8 ± 21.6 months, respectively. The majority of the patients presented with abdominal pain (59%), followed by diarrhea (47%), weight loss (20%), gastrointestinal bleeding (15%), and fever (11%). A history of taking non-steroidal anti-inflammatory drugs was present in only 5% of the patients. Mean hemoglobin, C-reactive protein, and albumin levels were 11.6 ± 2.8 g/dl, 6.9 ± 9.5 mg/l, and 3.7 ± 0.8 g/dl, respectively. Based on clinical, colonoscopic, and histopathological findings, initial treatment was symptomatic/antibiotics in 55%, anti-tubercular treatment in 21%, 5-aminosalicylic acid/steroids for Crohn’s disease in 13%, oral budesonide in 10% of patients, and one patient was referred for management of malignancy. Final diagnoses after 8-24 weeks of follow-up were non-specific ileitis/colitis (45%), Crohn’s disease (20%), intestinal tuberculosis (18%), infective (7%), eosinophilic ileitis/colitis (6%), non-steroidal anti-inflammatory drug-induced (2%), and amoebic and malignant in 1% of patients each.
Conclusions: The majority of patients with ileo-cecal ulcers have specific etiologies. Non-specific ulcers at the ileo-cecal region can be managed symptomatically; however close follow-up is necessary as sometimes the ulcers may harbor an underlying specific disease.
Relevance for patients: Isolated ileo-cecal ulcers are common findings during colonoscopy in both symptomatic and asymptomatic patients. The majority of these ulcers harbor underlying significant diseases that can cause morbidity and mortality if left undiagnosed and untreated. Reaching a specific diagnosis in such cases is not straightforward, and patients are often subjected to repeat examinations.
[1] Tang SJ, Wu R. Ilececum: A Comprehensive Review. Can J Gastroenterol Hepatol 2019;2019:1451835.
[2] Horvath KD, Whelan RL. Intestinal Tuberculosis: Return of an Old Disease. Am J Gastroenterol 1998;93:692–6.
[3] Moss JD, Knauer CM. Tuberculous Enteritis. A Report of Three Patients. Gastroenterology 1973;65:959–66.
[4] Iadicola D, De Marco P, Bonventre S, Grutta EM, Barletta G, Licari L, et al. Bowel Wall Thickening: Inquire or not Inquire? Our Guidelines. G Chir 2018;39:41-4.
[5] Al-Khowaiter SS, Brahmania M, Kim E, Madden M, Harris A, Yoshida EM, et al. Clinical and Endoscopic Significance of Bowel-wall Thickening Reported on Abdominal Computed Tomographies in Symptomatic Patients with no History of Gastrointestinal Disease. Can Assoc Radiol J 2014;65:67-70.
[6] Kedia S, Kurrey L, Mouli VP, Dhingra R, Srivastava S, Pradhan R, et al. Frequency, Natural Course and Clinical Significance of Symptomatic Terminal Ileitis. J Dig Dis 2016;17:36-43.
[7] Mehta V, Gupta A, Mahajan R, Narang V, Midha V, Sood N, et al. Symptomatic Isolated Terminal Ileal Ulcers: Etiology and Clinical Significance. Endosc Int Open 2017;5:E539-46.
[8] Agarwala R, Singh AK, Shah J, Mandavdhare HS, Sharma V. Ileocecal Thickening: Clinical Approach to a Common Problem. JGH Open 2019;3:456-63.
[9] Toshniwal J, Chawlani R, Thawrani A, Sharma R, Arora A, Kotecha HL, et al. All Ileo-cecal Ulcers are not Crohn’s: Changing Perspectives of Symptomatic Ileocecal Ulcers. World J Gastrointest Endosc. 2017;9:327-33.
[10] Liu JX, Wang HH. Clinical and Pathological Features of Benign Ileocecal Ulcerative Lesions Discovered by Ileocolonoscopy: Analysis of 31 Cases. Zhonghua Yi Xue Za Zhi 2008;88:823-5.
[11] Smith RL, Taylor KM, Friedman AB, Majeed A, Perera N, Gibson PR. Nonspecific Ileitis: Impact of Histopathology and Gastrointestinal Ultrasound in Achieving the Diagnosis of Crohn’s Disease. JGH Open 2022;6:388-94.
[12] Agrawal M, Miranda MB, Walsh S, Narula N, ColombelJF, Ungaro RC. Prevalence and Progression of Incidental Terminal Ileitis on Non-diagnostic Colonoscopy: A Systematic Review and Meta-analysis. J Crohns Colitis 2021;15:1455-63.
[13] Kumar A, Rana SS, Nada R, Kalra N, Sharma RK, Dutta U, et al. Significance of Ileal and/or Cecal Wall Thickening on Abdominal Computed Tomography in a Tropical Country. JGH Open 2018;3:46-51.
[14] Singh AK, Kumar R, Gupta P, Kumar MP, Mishra S, Mandavdhare HS, et al. FDG-PET-CT Enterography Helps Determine Clinical Significance of Suspected Ileocecal Thickening: A Prospective Study. Dig Dis Sci 2021;66:1620-30.
[15] Kumar S, Bopanna S, Kedia S, Mouli P, Dhingra R, Padhan R, et al. Evaluation of Xpert MTB/RIF Assay Performance in the Diagnosis of Abdominal Tuberculosis. Intest Res 2017;15:187-94.
[16] Du J, Ma YY, Xiang H, Li YM. Confluent Granulomas and Ulcers Lined by Epithelioid Histiocytes: New Ideal Method for Differentiation of ITB and CD? A Meta Analysis. PLoS One, 2014;9:e103303.
[17] Sharma V, Soni H, Kumar MP, Dawra S, Mishra S, Mandavdhare HS, et al. Diagnostic Accuracy of the Xpert MTB/RIF Assay for Abdominal Tuberculosis: A Systematic Review and Meta-analysis. Expert Rev Anti Infect Ther 2021;19:253-65.
[18] Pulimood AB, Amarapurkar DN, Ghoshal U, Phillip M, Pai CG, Reddy DN, et al. Differentiation of Crohn’s Disease from Intestinal Tuberculosis in India in 2010. World J Gastroenterol 2011;17:433-43.
[19] Kedia S, Das P, Madhusudhan KS, Dattagupta S, Sharma R, Sahni P, et al. Differentiating Crohn’s Disease from Intestinal Tuberculosis. World J Gastroenterol 2019;25:418-32.
[20] Sharma M, Sinha SK, Sharma M, Singh AK, Samanta J, Sharma A, et al. Challenging Diagnosis of Gastrointestinal Tuberculosis Made Simpler with Multi-targeted Loopmediated Isothermal Amplification Assay. Eur J Gastroenterol Hepatol 2020;32:971-5.
[21] Weng F, Meng Y, Lu F, Wang Y, Wang W, Xu L, et al. Publisher’s note Whioce Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Differentiation of Intestinal Tuberculosis and Crohn’s Disease through an Explainable Machine Learning Method. Sci Rep 2022;12:1714.
[22] Alfadda AA, Storr MA, Shaffer EA. Eosinophilic Colitis: Epidemiology, Clinical Features, and Current Management. Therap Adv Gastroenterol 2011;4:301-9.